News
After the surprise departure of longtime CEO Lars Fruergaard Jørgensen in May, Danish pharma giant Novo Nordisk didn’t take ...
Liraglutide injection single-patient-use prefilled pens and glucagon for injection vials will be manufactured at Lupin’s ...
Despite the recent buzz, the effort to reduce animal testing in favor of NAMs has been underway for years. The VQN falls ...
Barchart on MSN23h
Should You Buy the Post-Earnings Plunge in Novo Nordisk Stock or Stay Far, Far Away?
Novo Nordisk (NVO) stock shed over 21% on Tuesday after the Danish pharmaceutical giant slashed its guidance for the second time this year, leaving investors questioning whether the obesity drug ...
Second quarter 2025 revenues increased 4% to $3.68 billion versus second quarter 2024; Dupixent ® global net sales (recorded by Sanofi) increased 22% to $4.34 billion ; EYLEA HD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback